SCHEMBL1002234

SCHEMBL1002234

CNC(=O)c1cc(F)c(C(F)(F)F)c(F)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 6/20 0.44
HDAC1 Q13547 3/20 0.44
HTT P42858 2/20 0.40
KDM4E B2RXH2 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
GAA P10253 1/20 0.40
HDAC8 Q9BY41 2/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC4 P56524 1/20 0.39
PDK2 Q15119 2/20 0.38
PDE2A O00408 1/20 0.37
HPGD P15428 2/20 0.37
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ACSS2 Q9NR19 1/20 0.37
MAPT P10636 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CFTR P13569 1/20 0.36
PLK1 P53350 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7981473 0.79 CES2 (0.56) HDAC6HDAC1HTTGAAHDAC8
SCHEMBL1004064 0.78 HDAC6 (0.70) HDAC6HDAC1HTTGAAHDAC8
SCHEMBL28460682 0.77 CES2 (0.41) HDAC6HDAC1
SCHEMBL23826367 0.77 NOTUM (0.53) HTTKDM4EGAATSHRMAPT
SCHEMBL1005002 0.77 CFTR (0.43) HDAC6HTTKDM4ERXFP1HDAC8
SCHEMBL14214022 0.77 KIF11 (0.55) HDAC6HDAC1HDAC8HDAC2PDK2
SCHEMBL21783935 0.76 HDAC6 (0.68) HDAC6HDAC1HTTGAAHDAC8
SCHEMBL1004777 0.76 CES2 (0.59) HDAC6HTTKDM4EGAAHDAC8
SCHEMBL3875496 0.75 RXRA (0.46) HTTKDM4EHPGDTSHRSMN1; SMN2
SCHEMBL38657509 0.74 HDAC1 (0.47) HDAC6HDAC1HTTGAAHDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115551864-A Substituted tricyclic amides, analogs thereof, and methods of using the same 爱彼特生物制药公司 2022-12-30 CN disclosed
US-8535560-B2 Ionic liquids for separation of olefin-paraffin mixtures UT-BATTELLE, LLC (US) 2013-09-17 US disclosed
US-20110015461-A1 Ionic Liquids for Separation of Olefin-Paraffin Mixtures UT-BATTELLE, LLC (US) 2011-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110015461-A1 Ionic Liquids for Separation of Olefin-Paraffin Mixtures POU2F1, POU2F2, POF1B HDAC6 4094/4885HDAC1 3902/4885HTT 3924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.